Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vik

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cancer Medicine|November 24, 2021
Cancer prevention, screening, and survivorship ECHO: A pilot experience with an educational telehealth programTyler S Severance, Zheng Milgrom, Anyé Carson, et al.
Pediatric Blood & Cancer|May 10, 2018
Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in KenyaSaskia Mostert, Festus Njuguna, Renske H M van der Burgt, et al.
Blood|May 12, 2005
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemiaRobert J Arceci, Jane Sande, Beverly Lange, et al.
International Journal of Cancer|May 3, 2016
Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort studyGeoffrey Buckle, Louise Maranda, Jodi Skiles, et al.
Pediatric Blood & Cancer|November 9, 2017
CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancerJodi L Skiles, ChienWei Chiang, Claire H Li, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphomaCatherine S Forconi, Lauren Shumate, Zachary Racenet, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cancer Medicine|November 24, 2021
Cancer prevention, screening, and survivorship ECHO: A pilot experience with an educational telehealth programTyler S Severance, Zheng Milgrom, Anyé Carson, et al.
Pediatric Blood & Cancer|May 10, 2018
Health-care providers' perspectives on health-insurance access, waiving procedures, and hospital detention practices in KenyaSaskia Mostert, Festus Njuguna, Renske H M van der Burgt, et al.
Blood|May 12, 2005
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemiaRobert J Arceci, Jane Sande, Beverly Lange, et al.
International Journal of Cancer|May 3, 2016
Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort studyGeoffrey Buckle, Louise Maranda, Jodi Skiles, et al.
Pediatric Blood & Cancer|November 9, 2017
CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancerJodi L Skiles, ChienWei Chiang, Claire H Li, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphomaCatherine S Forconi, Lauren Shumate, Zachary Racenet, et al.
The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.
Pageof 10